MedPath

Web-Enhanced Guideline Implementation for Post MI CBOC Patients

Not Applicable
Completed
Conditions
Myocardial Infarction
Comorbidity
Interventions
Behavioral: VA MI Plus Interactive
Registration Number
NCT00126750
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

To assist busy primary care clinicians in VA Community Based Outpatient Clinics (CBOCs) in managing complex patients by providing a single, interactive, and personalized source of information regarding applicable guidelines for post-MI patients. Specifically, 1) the investigators will identify barriers to provider adherence to guidelines within VHA clinics; 2) Apply guideline-based performance measures to electronic medical records (CPRS) and associated administrative data; 3) Implement the interactive Internet intervention developed by the NHLBI study, after inclusion of VA-specific components, including performance feedback for CBOC clinicians; and 4) Test hypotheses on the intervention's effectiveness, sustainability, and cost-effectiveness in both the VA and Medicare populations. This will include a randomized controlled trial with the CBOC as a unit of randomization.

Detailed Description

Some 7.1 million Americans and an estimated 250,000 Veterans actively using VHA are Myocardial Infarction (MI) survivors. To date, most guideline interventions focus on a single patient condition, but ambulatory post-MI patients are frequently more complex, multiple comorbidities, and conflicting guidelines applicable to them. For example, whereas JNC-6 guidelines for the treatment of hypertension suggest pharmacological treatment at blood pressures above 140/80 mm Hg, to be initiated with diuretics or beta-blockers as first line agents, other guidance suggests that for post-MI patients with diabetes, treatment cut-offs should be lower and ACE-inhibitors may be considered as optimal first-line agents. On October 1, 2002, the University of Alabama at Birmingham (UAB) began a study funded by the National Heart, Lung, and Blood institute (NHLBI) as an RO1 (Kiefe, PI (25%), Weissman, co-PI (20%)) to conduct a randomized trial, MI-plus to increase provider adherence to guidelines for post-MI patients. That NHLBI-funded study targets Medicare beneficiaries and their primary care providers in Alabama. Its primary goal is to develop and test with a randomized controlled trial, an Internet-based multimodal guideline implementation strategy. The investigators propose, herewith, to extend and adapt this study to a nationwide sample of VA post-MI patients and their primary care providers in the VA.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
847
Inclusion Criteria

Potential subjects are defined as any VA-employed physician, PA, or CRNP who is a CBOC provider. All such providers will be offered the opportunity to participate and will have the option to agree to participate or not. Performance measure data from records of post-MI patients of the above providers will be extracted to test the experimental intervention. (Note: No individually identifying patient information will be extracted.) All VA-employed CBOC providers (physicians, PAs, CRNPs) will be offered the opportunity to participate in this study. Any subject may refuse to participate or to discontinue participation at will at any point in the study without consequence.

Read More
Exclusion Criteria

Potential subjects must be VA-employed physician, PA, or CRNP who is a CBOC provider. No such healthcare providers will be excluded from the study.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm 1VA MI Plus Interactive-
Primary Outcome Measures
NameTimeMethod
Primary Outcome Was the Performance of Each Provider on Each of Seven Clinical Indicators1/1/02 - 12/31/08

The investigators used an intent-to-treat approach for our main analysis, basing our outcome measures on provider's eligible patient population in each of the clinics. Performance improvement was calculated at the change (before vs after the intervention) the percentage of provider's patients with each clinical indicator. 1) change in the percentage of patients with improvements in LDL. Improvement defined as LDL-C level \< previous 18 mos; 2) Change in the percentage of patients with improvements in A1c. Improvement defined as HbA1c level \< previous 18 mos; 3) Change in percentage of patients prescribed Beta Blockers; 4) Change in the percentage of patients prescribed Statins; 5) Change in the percentage of patients prescribed ACEI or ARB; 6) Change in percentage of patients reaching target goal for LDL-C (\<100mg/dL); 7) Change in percentage of patients reaching target goal for HbA1c (\<8%).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (40)

Overton Brooks VA Medical Center, Shreveport, LA

🇺🇸

Shreveport, Louisiana, United States

VA Boston Health Care System, Jamaica Plain

🇺🇸

Boston, Massachusetts, United States

Long Beach

🇺🇸

Long Beach, California, United States

Bay Pines VA Healthcare System, Pay Pines, FL

🇺🇸

Bay Pines, Florida, United States

VA Medical Center, Decatur

🇺🇸

Decatur, Georgia, United States

Jesse Brown VAMC (WestSide Division)

🇺🇸

Chicago, Illinois, United States

VA Illiana Health Care System

🇺🇸

Danville, Illinois, United States

VA Medical Center Iowa City

🇺🇸

Iowa City, Iowa, United States

VA Medical Center, Louisville

🇺🇸

Louisville, Kentucky, United States

Edith Nourse Rogers Memorial Veterans Hospital

🇺🇸

Bedford, Massachusetts, United States

VA Ann Arbor Healthcare System

🇺🇸

Ann Arbor, Michigan, United States

Battle Creek, MI

🇺🇸

Battle Creek, Michigan, United States

No Longer Valid, Use 528A8

🇺🇸

Albany, New York, United States

Harry S. Truman Memorial VA Medical Center

🇺🇸

Columbia, Missouri, United States

Kansas City VA Medical Center

🇺🇸

Kansas City, Missouri, United States

VA Medical Center, St Louis

🇺🇸

St Louis, Missouri, United States

Albany VA Medical Center: Samuel S. Stratton

🇺🇸

Albany, New York, United States

Franklin Delano Roosevelt Campus of VAHVHCS

🇺🇸

Montrose, New York, United States

New York, NY

🇺🇸

New York, New York, United States

VA Medical Center, Cleveland

🇺🇸

Cleveland, Ohio, United States

Coatesville, PA

🇺🇸

Coatesville, Pennsylvania, United States

Lebanon, PA

🇺🇸

Lebanon, Pennsylvania, United States

VA Medical Center, Providence

🇺🇸

Providence, Rhode Island, United States

William S. Middleton Memorial Veterans Hospital

🇺🇸

Madison, Wisconsin, United States

VA Eastern Kansas Health Care System - Topeka

🇺🇸

Topeka, Kansas, United States

VA Medical Center, Birmingham

🇺🇸

Birmingham, Alabama, United States

Carl T. Hayden VA Medical Center

🇺🇸

Phoenix, Arizona, United States

VA Medical Center, Miami

🇺🇸

Miami, Florida, United States

VA Medical Center, Cincinnati

🇺🇸

Cincinnati, Ohio, United States

VA Salt Lake City Health Care System, Salt Lake City

🇺🇸

Salt Lake City, Utah, United States

Clement J. Zablocki VAMC

🇺🇸

Milwaukee, Wisconsin, United States

San Juan VAMC

🇵🇷

San Juan, Puerto Rico

VA Medical & Regional Office Center, White River

🇺🇸

White River Junction, Vermont, United States

Fayetteville, AR

🇺🇸

Fayetteville, Arkansas, United States

VA Connecticut Health Care System (West Haven)

🇺🇸

West Haven, Connecticut, United States

VA Medical Center

🇺🇸

Nashville, Tennessee, United States

VA Gulf Coast Veterans Health Care System

🇺🇸

Biloxi, Mississippi, United States

VA New Jersey Health Care System, East Orange

🇺🇸

East Orange, New Jersey, United States

Ralph H Johnson VA Medical Center, Charleston

🇺🇸

Charleston, South Carolina, United States

Robert J. Dole VAMC & ROC

🇺🇸

Wichita, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath